Related Experiment Video
Updated: Dec 27, 2025
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Surgical treatment of a primary malignant pericardial mesothelioma: case report
G Apicella1, A Boulemden1, A Citarella1
1Department of Trent Cardiac Centre, Nottingham University Hospitals, Nottingham, UK.
Abstract:
Pericardial malignant mesothelioma (MM) is a rare tumour which accounts for about 1% of all mesotheliomas, 4% of the primary heart and pericardial tumours. It carries an extremely poor prognosis, with a reported overall survival of less than 6 months. Clinical symptoms and signs are frequently nonspecific, and the diagnosis is usually made after surgery or at autopsy. We report a case of a 72 years old woman with primary pericardial malignant mesothelioma involving the right atrium. Nine months following surgery, the patient is alive with good performance status.
Insights
Pericardial malignant mesothelioma (MM) is a rare cancer with a poor prognosis. This case report highlights a successful surgical outcome for a patient with primary pericardial MM involving the right atrium.
Area of Science:
- Cardiovascular Pathology
- Thoracic Oncology
- Rare Tumors
Background:
- Pericardial malignant mesothelioma (MM) is a rare neoplasm, constituting 1% of all mesotheliomas and 4% of primary heart/pericardial tumors.
- This malignancy carries a dismal prognosis, with reported overall survival typically under 6 months.
- Clinical presentation is often nonspecific, leading to delayed diagnosis, frequently post-surgical or post-mortem.
